Deyu Li

A randomized, double‐blind, placebo‐controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS‐CoV‐2 vaccine SCoK in adults

X. Wang, Y. Li, X. Fang, 2022, Clinical and translational medicine.

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants

Tao Li, Hui Wang, De-yan Luo, 2022, Signal Transduction and Targeted Therapy.

Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients

Tao Li, Hui Wang, Z-h Wei, 2021, Frontiers in Microbiology.

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults

X. Wang, Tao Li, Hui Wang, 2023, Emerging microbes & infections.

Acinetobacter baumannii adaptation to the host pH microenvironment is mediated by allelic variation in a single residue of BauA protein

Tao Li, Hui Wang, F. Qu, 2023, PNAS nexus.